Workshops & Seminars

  • Home
  • Workshops & Seminars

Planova™ Workshops and Local Seminars

The Planova Workshop is an opportunity for Planova users to share experiences and to learn the best practices of virus filtration. Event chairs and speakers at this annual event are key industry leaders in biotherapeutics, and their presentations cover topics such as tips for process optimization, validations, regulatory requirements and scaling up to commercial manufacturing. Event attendees include experts in the fields of regulation, process development, pathogen safety, quality and manufacturing. Since the first Planova Workshop held in 1998 in Oslo, Norway, this annual event has greatly contributed to raising awareness on viral safety as well as effective use of virus filtration in the manufacturing processes of biotherapeutics.

Planova Local Seminars are similar events tailored to the needs of certain local regions, with additions of presentations covering case studies from global and local companies as well as regulatory updates on viral safety specific to the region.

In this Page, you can explore details of the upcoming events as well as download materials available from past events (login required).

Upcoming Events

Below you can find details of the upcoming events, including registration forms once they are available.

Planova™ Seminar 2019, China

Apr 11, 2019 to Apr 12, 2019
Hangzhou, China

Latest Workshops

Below you can find details of the last five Planova Workshops and download the presentation materials (login required). To find information on other previous Planova Workshops, click Archive.

Latest Seminars

Below you can find details of the last five Local Seminars and download the presentation materials (login required). To find information on other previous Local Seminars, click Archive.

Search Presentations

Here you can search and download (login required) presentation materials from past Planova Workshops, by entering keyword or by using filters for each category.

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to download the files.

155 Results Found

  1. 10
  2. 20
  3. 30
  4. All
  1. Challenges of implementing virus filtration in continuous manufacturing

    Daniel Strauss, Ph.D., Principal Scientist Science and Technology
    Asahi Kasei Bioprocess America
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  2. Evaluating the Impact on Viral Clearance of Multiple Unplanned Interruptions During Virus Removal Filtration

    Kevin K. Okimura, Senior Manager Outsourced Manufacturing
    Portola Pharmaceuticals
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  3. Clearing the way for viral clearance

    David Cetlin, Founder/C.E.O.
    MockV Solutions
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  4. Of future biotechnology options and the central role of nanofiltrarion

    Andreas Wieser, D (I FH), Senior Laboratory Associate Global Pathogen Safety
    Shire
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  5. Meeting Planova and Selecting BioEX for Our Monoclonal Antibody Manufacturing Process

    Yumiko Masuda, Scientist Biologics Technology Research Laboratories Biologics Division
    Daiichi Sankyo
    Meeting Planova and Selecting BioEX for Our Monoclonal Antibody Manufacturing Process
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  6. Challenges & Strategies for Viral Filtration

    Matt (Mingjiang) Luo, Ph.D., Executive Director Downstream Process Development and Haikuan Liu, Ph.D., Associate Director Downstream Process Development
    Wuxi Biologics (Shanghai)
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  7. A Case Study: Evaluation of the Effect of Process Pause and Pressure Variation on Planova 20N Virus Filter

    Samuel Vollert, Process Development Scientist I Downstream Process Development
    Patheon (Thermo Fisher Scientific)
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  8. Clarification Impurities Impact Viral Filtration of a Therapeutic Antibody

    Ryan Zolyomi, Senior Development Associate Isolation & Purification Biological Development
    Bayer U.S.
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  9. Visualization of behavior of virus and proteins in Planova membrane filters using advanced microscope system with confocal optics

    Takayuki Nishizaka, Ph.D., Professor, Department of Physics
    Gakushuin University
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  10. Different apparent Size of Parvoviruses determined by Virus Filtration

    Thomas Nowak, Ph.D., Senior Manager Pathogen Safety
    CSL Behring
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  11. Establishing a Virus Filter Design Space - Impact of Process Interruption on Parvovirus Retention

    Ashlee Smith, Associate Scientist BioTherapeutics Development - API; Discovery, Product Development & Supply
    Janssen Research & Development
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  12. Overview of Challenges in Virus Filtration: Principles and Applications

    Tomoko Hongo-Hirasaki, Ph.D., Senior Scientist Evaluation and Analysis in Virus Filtration Bioprocess Division
    Asahi Kasei Medical
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  13. A Review of Virus Filter Performance

    Horst Ruppach, Ph.D., Director, Viral Clearance and Virology Biologics Testing Solutions
    Charles River Laboratories
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  14. Update on European Regulations

    Johannes Blümel, Ph.D., Head of Virus Safety Section Department of Virology
    Paul-Ehrlich-Institut
    21st Planova Workshop
    Oct 11, 2018 to Oct 12, 2018
    San Francisco, CA, USA

  15. Consistent and Reliable 100% Retrovirus Removal by Planova™ 20N filter: Demonstration of Robust Log Reduction (>6.0) by Co-spiking Study

    Dayue Chen, Virology Group Bioprocess Research and Development, Eli Lilly and Company
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  16. Virus Inactivation at Low pH: Impact of Buffers, pH Value, Protein Concentration and Temperature on the Inactivation of Retroviruses

    Michael Dieterle, Associate Director Downstream Development, Boehringer Ingelheim GmbH&Co.KG
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  17. Implementation of Quality by Design to Nanofiltration of Plasma Products

    Monique Ollivier, Director, Process Development-Downstream & Analytics, Cytheris S.A.
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  18. FULL PLASTICS for a 1000L Disposable Production Line for Generic Antibody Manufacturing

    Peter Rogge, Director, DSP Production, Rentschler Biotechnologie GmbH
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  19. New Concept of Integrity Test for Planova™ BioEX

    Shinya Sekine, Manager, Technology Development Department, Asahi Kasei Medical Co., Ltd.
    14th Planova™ Workshop
    Nov 9, 2011 to Nov 10, 2011
    Cologne

  20. PDA Technical Report 41: Virus Filtration - History and the Future

    Kurt Brorson, Staff Scientist, CDER, FDA
    15th Planova™ Workshop
    Jun 14, 2012 to Jun 15, 2012
    Boston